‘Zombie Drug’ Video Sparks Alarm, But Experts Urge Caution Before Sharing

A disturbing video purporting to show the effects of a so-called “zombie drug” has been circulating widely on social media platforms, prompting concern among health officials and digital media experts alike. The footage, which depicts individuals in various states of physical distortion and impaired consciousness, has generated significant alarm—but authorities are urging the public to pause before hitting the share button.

The video claims to show the effects of xylazine, a veterinary tranquilizer that has increasingly found its way into recreational drug supplies across various regions. Known colloquially as “tranq” or the “zombie drug,” xylazine has become a growing concern for health authorities due to its dangerous effects when combined with opioids like fentanyl.

However, fact-checkers and health experts caution that the viral video may be misrepresenting the situation. Dr. Samantha Reeves, an addiction medicine specialist at University Medical Center, explains that while xylazine does pose serious health risks, the dramatic behaviors depicted in the video may be exaggerated or incorrectly attributed.

“What we’re seeing is potentially a mix of different substances or conditions being labeled under one sensational term,” said Dr. Reeves. “This kind of misinformation can actually hamper public health efforts by creating unnecessary panic or reinforcing harmful stereotypes about addiction.”

Digital media analyst Rajiv Sharma points out that such videos often gain traction because they play into existing fears. “There’s a pattern to how these ‘drug scare’ videos circulate. They tap into deep societal anxieties about drug epidemics, and people share them with good intentions—thinking they’re warning others about a danger—but often without verifying the content.”

Law enforcement agencies across several states have reported increases in xylazine-laced drug seizures over the past year. The drug, which is not approved for human use, can cause serious side effects including severe skin ulcers, respiratory depression, and dangerous drops in blood pressure. What makes xylazine particularly concerning is that it doesn’t respond to naloxone, the medication commonly used to reverse opioid overdoses.

The Centers for Disease Control and Prevention (CDC) reported that xylazine was involved in approximately 11% of overdose deaths in 2022, up from less than 2% five years earlier. The substance has been particularly prevalent in the Northeast but is spreading to other regions of the United States.

Public health officials emphasize that sharing unverified videos can have unintended consequences beyond spreading misinformation. “These videos often dehumanize people struggling with addiction,” notes Maria Gonzalez, director of a community harm reduction program in Philadelphia. “They can deepen stigma and make individuals less likely to seek the help they need.”

Instead of forwarding alarming videos, experts suggest more constructive approaches to addressing substance use concerns. “If you’re worried about drug use in your community, connect with local harm reduction organizations or public health departments,” advises Gonzalez. “They can provide accurate information and resources that actually help people.”

Social media platforms have implemented various measures to flag potentially misleading content, but the rapid nature of sharing often outpaces these safeguards. Users are encouraged to verify information through reliable sources before sharing and to consider the potential impact of distributing graphic or sensationalized content.

“Before you share something shocking, ask yourself: Do I know this is accurate? Am I potentially contributing to misinformation? Could this harm vulnerable individuals?” suggests Sharma.

While the concerns about xylazine are legitimate, experts emphasize that addressing the complex issues of addiction and illicit drug use requires factual information, compassion, and evidence-based approaches—not viral sensationalism.

If you or someone you know is struggling with substance use, resources are available through the Substance Abuse and Mental Health Services Administration’s helpline at 1-800-662-HELP (4357).